Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative methadone for prevention of postoperative pain in orthopedic surgery
2023-000172-36Phase 3Active
- Sponsor
- CHU Brugmann
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Intraoperative methadone with Standard-dose sufentanil (2 arms). Primary endpoints: Total morphine consumption in the first 24 postoperative hours, Postoperative pain scores over 24 hours and 2 more. Started Jan 2023; status: active.
02
Drugs
methadonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2023-000172-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000172-36.